Clinical Trials Directory

Trials / Unknown

UnknownNCT03460392

Study of Human Microbiota in Healthy and Pathological Conditions

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of the present study is to characterize the bacterial composition (microbiota) colonizing to the human body in different physio - pathological conditions (lifestyle, motor activity, surgical operations, probiotic and prebiotic consumption, antibiotic therapies, chemotherapeutic therapies), nervous and musculoskeletal diseases, gastrointestinal and metabolic disorders , oral and vaginal diseases, etc.). In particular, they will be investigate: * the changes in the bacterial abundance * the potential microbial interactions with the human host * the microbial networks describing on the bacterial interactions within a specific composition of the human microbiota

Detailed description

The main objective of this study is to deepen the knowledge about the bacterial communities associated to the human organism. In particular, the present study aims to evaluate how the microbiota (intestinal, cutaneous, vaginal, nasal, bronchial, breast milk, salivary, oral, etc.) is subject to quantitative and qualitative changes consequently to different events involving the human host. The project trys to highlight which microorganisms may be involved in the onset or progression of certain pathological condition, as well as to identify which bacterial genera can be more subject to variations due to specific non-pathological events. Secondary objectives of this study are: * To define a "healthy microbiome", that is to understand which are the main bacteria that commonly compose the human microbiome in physiological conditions, differentiating it from that present in certain pathological conditions. * To characterize the physiological effects that bacterial changes of the human microbiota have on the host. * To evaluate whether the use of probiotics, prebiotics, dietary and nutritional factors, cosmetics, and oral, nasal, vaginal, or pharmacological therapies of any kind can influence the microbial network of the human microbiota associated to different body districts.

Conditions

Interventions

TypeNameDescription
DRUGAntibiotic therapyTo evaluate the effects of a specific event (i.e. surgical operation) or therapy (i.e antibiotic treatment) over time;

Timeline

Start date
2017-06-12
Primary completion
2017-07-31
Completion
2019-12-31
First posted
2018-03-09
Last updated
2018-03-09

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03460392. Inclusion in this directory is not an endorsement.